1 cardiopulmonary changes after treatment with ganglionic blocker.

2 r changes were observed in the presence of a ganglionic blocker.

3 hose BAT thermogenesis was inhibited using a ganglionic blocker.

4 1 stimulation was eliminated by splenectomy, ganglionic-blocker administration or beta2-adrenergic re

5 posure in rats pretreated with saline or the ganglionic blocker chlorisondamine (5 mg/kg).

6        Some noncompetitive inhibitors (e.g., ganglionic blockers) exhibit selectivity for the inhibit

7 heart rate and mean arterial pressure to the ganglionic blocker hexamethonium and decreased urinary n

8 nt with chlorisondamine (2.5 mg/kg, i.v.), a ganglionic blocker, indicating its dependence on the sym

9 or BTMPS), a bifunctional form of the potent ganglionic blocker tetramethylpiperidine.

10 sis, seven individuals were infused with the ganglionic blocker trimetaphan before and after an 8 h e

11 ed animals or in animals pretreated with the ganglionic blocker trimethaphan, confirming their reflex